Effect of Nonselective β-Blockers on Mortality in Patients With End-Stage Cirrhosis.

Conclusion and Relevance: In patients with end-stage cirrhosis, use of NSBBs did not affect 24-month mortality. More research is needed to determine when, and if, NSBBs should be discontinued in end-stage cirrhosis.
PMID: 31701773 [PubMed - as supplied by publisher]

Source: The Annals of Pharmacotherapy - November 7, 2019 Category: Drugs & Pharmacology Authors: Snoga JL, Lusk KA, Attridge RT, Attridge RL Tags: Ann Pharmacother Source Type: research